MRRS adds "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand" latest studies, published in December 2016. It is a professional and in-depth study.

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Thailand”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2015, the population of Thailand 68.84 million, and it is estimated to reach 69.31 million by 2020. The value of the pharmaceutical market was estimated at $5.91 billion in 2015, and is expected to reach $9.47 billion in 2020, increasing at a projected CAGR of 10%.

The positive trends in the healthcare market of Thailand can be attributed primarily to –
– Increasing medical tourism
– Increasing health awareness
– Greater access to life-saving facilities

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes –
– An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Sanofi, Roche, AstraZeneca and Novartis.
– An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices
– Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures
– An overview of the opportunities and challenges for growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving Thailand’s healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand’s healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Press Release

Medical tourism will drive Thailand’s pharmaceutical market towards $9.5 billion by 2020, says GlobalData

The pharmaceutical market in Thailand is expected to rise from $5.91 billion in 2015 to $9.47 billion by 2020, at a compound annual growth rate (CAGR) of 10%, according to research and consulting firm GlobalData.

The company’s latest report states that the primary driver of this strong pharmaceutical expansion in Thailand is the treatment of chronic diseases in the elderly population. Indeed, obesity and other non-communicable diseases such as diabetes, hypertension, and cancer have increased over the past few years due to an increasing elderly population and unhealthy lifestyles.

As the country moves towards becoming Asia’s healthcare hub through its medical tourism sector, the pharmaceutical industry is riding on its success. Thailand attracts an average of two million foreign patients per year due to the fact that its healthcare costs are only around one-fifth of those in the US and Europe. In 2012, Thailand generated $1.84 billion from medical tourism, and this figure reached $4.7 billion in 2015, helping to enhance the country’s research and clinical trials of advanced medicine and stem cell treatments.

A number of government initiatives have also boosted the country’s pharmaceutical industry. The 11th National Economic and Social Development Plan (2012-2016) and the Second National Plan for Older Persons (2002-2021) are the major government-implemented programs in Thailand. The aim of the latter is to improve quality of life for the elderly population by providing them with easy availability of medical services.

An increase in the number of public hospitals has also led to a rise in healthcare expenditure. The number of public hospitals grew during the 2008-2015 period at a CAGR of 4%, increasing citizens’ access to affordable healthcare facilities, and this expansion will continue to drive the market.
– Information based on GlobalData’s report: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Thailand.
– This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

Browse Complete Report with TOC @
[URL]http://www.marketresearchreportstore.com/shop/countryfocus-healthcare-regulatory-and-reimbursement-landscape-thailand[/URL]

Ask a sample or any question, please feel free to contact us:

Tel: +00-1-626-3463946 - U.S

Email: [email protected]

[URL]http://www.marketresearchreportstore.com/[/URL]


About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.